ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
3.04
0.00
(0.00%)
終了 1月18日 6:00AM
3.04
0.00
( 0.00% )
プレマーケット: 9:00AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
3.04
買値
3.01
売値
3.10
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
3.04
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

ITEK 最新ニュース

Inotek Pharmaceuticals Announces Filing of Preliminary Proxy Statement for Proposed Merger with Clinical-stage Gene Therapy C...

- First Clinical Program in Fanconi Anemia Demonstrating Early Hematological Stabilization in Patients - - Additional First-in-human Results from up to Three Programs Expected in 2018...

INSERTING & REPLACING Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of Fi...

- Company to Leverage Lentiviral and AAV Gene Therapy Platforms to Target Rare Genetic Diseases - - Transaction to Advance Rocket’s Growing Pipeline; Up to Four Clinical Trials to Begin...

Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Ther...

- Company to Leverage Lentiviral and AAV Gene Therapy Platforms to Target Rare Genetic Diseases - - Transaction to Advance Rocket’s Growing Pipeline; Up to Four Clinical Trials to Begin...

Inotek Pharmaceuticals Corporation Reports Second Quarter 2017 Financial Results and Operational Highlights

Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases...

Inotek Pharmaceuticals Announces Top-line Results of Phase 2 Fixed-dose Combination Trial of Trabodenoson & Provides Corporat...

- Trabodenoson FDC Demonstrated Moderate IOP Reduction Over Latanoprost Alone When Dosed in the Morning, But Had Comparable Efficacy Dosed in the Afternoon, and at Day 56 – - Company...

Inotek Pharmaceuticals Corporation Reports First Quarter 2017 Financial Results and Operational Highlights

Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases...

Inotek Pharmaceuticals Presents Preclinical Data on Trabodenoson at the Association for Research in Vision & Ophthalmology (A...

Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases...

Inotek Completes Patient Recruitment in Phase 2 Trial of a Fixed-dose Combination (FDC) of Trabodenoson and Latanoprost

- Scheduled to Meet with FDA on Monotherapy Program – Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development...

Inotek Pharmaceuticals Corporation Reports Fiscal Year 2016 Financial Results and Operational Highlights

Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases...

Inotek Pharmaceuticals Announces Participation at Upcoming Investor Conferences

Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ITEK - Frequently Asked Questions (FAQ)

What is the current INOTEK PHARMACEUTICALS CORP share price?
The current share price of INOTEK PHARMACEUTICALS CORP is US$ 3.04
What is the 1 year trading range for INOTEK PHARMACEUTICALS CORP share price?
INOTEK PHARMACEUTICALS CORP has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ASSTAsset Entities Inc
US$ 0.856
(84.28%)
23.97M
BBGIBeasley Broadcast Group Inc
US$ 13.17
(59.25%)
19
QETAQuetta Acquisition Corporation
US$ 16.82
(59.13%)
88
EDRYEuroDry Ltd
US$ 18.08
(58.88%)
12
LXEOLexeo Therapeutics Inc
US$ 7.99
(57.59%)
1
GOEVCanoo Inc
US$ 0.3586
(-73.44%)
1.62M
ELVNEnliven Therapeutics Inc
US$ 10.11
(-52.91%)
20
CUBLionheart Holdings
US$ 5.11
(-49.51%)
1
ALRSAlerus Financial Corporation
US$ 12.01
(-38.79%)
13
MDXGMiMedx Group Inc
US$ 6.01
(-34.10%)
9
CRKNCrown Electrokinetics Corporation
US$ 0.1282
(2.56%)
74.76M
ASSTAsset Entities Inc
US$ 0.856
(84.28%)
23.97M
NIVFNewGenIvf Group Ltd
US$ 0.3758
(7.68%)
19.17M
CGBSCrown LNG Holdings Ltd
US$ 0.825
(10.32%)
12.15M
RIMEAlgorhythm Holdings Inc
US$ 0.0399
(-4.09%)
9.34M

最近閲覧した銘柄

Delayed Upgrade Clock